Genome of Europe has published a White paper for representatives from ministries of health and science, health authorities and professionals.
As part of a deliverable, GoE has compiled a White paper which emphasizes the urgent need for increased investment in disease prevention to extend healthy lifespans and reduce healthcare costs in Europe. It highlights the potential of the “1+ Million Genomes” initiative and projects stemming from it to revolutionize disease prevention and personalised treatment through large-scale genomic data infrastructure and research. The compilation of the White paper is the first step in the process of approaching decision- and policymakers and healthcare professionals. This will be distributed on face-to-face meetings, round-table discussions and via direct contact to relevant stakeholders.
With the dissemination of this White paper we expect to increase awareness and prioritization of genomic research and use of genetics in healthcare in Europe. We expect politicians and decision makers to become more aware of the urgent need for investment in disease prevention and the potential benefits of genomic data initiatives, like Genome of Europe. We expect the White paper to contribute to drive the creation of supportive policies and the allocation of more funding towards genomic research, ultimately aiming to improve public health and reduce healthcare costs across Europe.